Get Ahead of Market Trends: Exclusive Access to Premium Research

Premium Research Reports, Intrinsic Value Models for Companies in Our Coverage Ecosystem, & Portfolio Dashboard.

We’ve been digging deep into the businesses in our coverage ecosystem lately (Tesla & Uber this coming week & any material events that influence any business in our coverage) — from Rocket Lab’s (RKLB) bold acquisition moves to AST SpaceMobile’s (ASTS) breakthrough in defense, Coherus BioSciences’ (CHRS Now Coherus Oncology) exciting oncology collaborations, and Nvidia’s (NVDA) explosive Q1. Our reports are packed; we give you everything you need. Even Transcripts/Q&A of quarterly/annual reports.

Here’s the best part (Only until July 1st):

For a limited time, you can access it all at a discounted rate! 🎉

Many have already taken advantage of this offer because you are locked in at the discounted price. By signing up, you’ll get full access to the detailed analyses we’ve published in our coverage, including Rocket Lab, AST SpaceMobile, Coherus BioSciences, and Nvidia this past week, along with our updated Intrinsic Value Tracker (IVT) models.

This week, we’ve also made moves in the portfolio: we’ve added positions in Coherus BioSciences & Relay Therapeutics while also slightly increasing our valuation for Nvidia—showing the accuracy of our models and how they help guide investment decisions.

This offer only last until July 1st, so it’s not permanent. I just want to give existing subscribers to have first dibs/priority. Visit our website below, use “PCRLAUNCH” at checkout for coupon code, & unlock your subscription today at a discounted rate.

Plus, check out the Q1 reports for Nvidia, Coherus, and others where we’ve provided a brief IVT model overview of how our valuations hold up & the accuracy. We will continue to post weekly abstracts of the reports we published here as well!